An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

Recently, metastatic renal cell carcinoma (mRCC) treatment has changed dramatically with the onset of new therapies against molecular targets replacing immunotherapy as standard treatment. We report the case of a 49-year-old patient with a moderately differentiated renal clear cell carcinoma without...

Descripción completa

Detalles Bibliográficos
Autores principales: Chara, Luis, Rodríguez, Beatriz, Holgado, Esther, Ramírez, Natalia, Fernández-Rañada, Isabel, Mohedano, Nicolás, Arcediano, Alberto, García, Inés, Cassinello, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: December, 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251249/
https://www.ncbi.nlm.nih.gov/pubmed/22220154
http://dx.doi.org/10.1159/000335016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251249/
https://www.ncbi.nlm.nih.gov/pubmed/22220154
http://dx.doi.org/10.1159/000335016

Ejemplares similares